Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland

Prostate

Volumn 66, Issue 6, 2006, Pages 591-603

  Bjartell, Anders ^a,c   Johansson, Rebecka ^a   Björk, Thomas ^a   Gadaleanu, Virgil ^b   Lundwall, Åke ^b   Lilja, Hans ^b,c   Kjeldsen, Lars ^d   Udby, Lene ^d  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Androgen; CRISP 3; Prostate specific antigen; SGP28; Tissue microarray

Indexed keywords

CYSTEINE; CYSTEINE RICH SECRETORY PROTEIN 3; PROSTATE SPECIFIC ANTIGEN; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE METASTASIS; CARCINOMA IN SITU; CLINICAL ARTICLE; GLEASON SCORE; HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METASTASIS; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TRANSURETHRAL RESECTION;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SALIVARY PROTEINS; SEMINAL PLASMA PROTEINS;

EID: 33645906530     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20342     Document Type: Article

References (47)

1. Jensen OM, Esteve J, Moller H, Renard H. Cancer in the European Community and its member states. Eur J Cancer 1990;26(11-12):1167-1256.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55(1):10-30.
3. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2(9):533-543.
4. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317(15):909-916.
5. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324(17):1156-1161.
6. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, Lovgren T. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991;37(9):1618-1625.
7. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51(1):222-226.
8. Brawer MK, Cheli CD, Neaman IE, Goldblatt J, Smith C, Schwartz MK, Bruzek DJ, Morris DL, Sokoll LJ, Chan DW, Yeung KK, Partin AW, Allard WJ. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol 2000;163(5):1476-1480.
9. Asmann YW, Kosari F, Wang K, Cheville JC, Vasmatzis G. Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags. Cancer Res 2002;62(11):3308-3314.
10. Kosari F, Asmann YW, Cheville JC, Vasmatzis G. Cysteine-rich secretory protein-3: A potential biomarker for prostate cancer. Cancer Epidemiol Biomarkers Prev 2002;11(11):1419-1426.
11. Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klaren R, Grone EF, Wiesel M, Gudemann C, Kuster J, Schott W, Staehler G, Kretzler M, Hollstein M, Grone HJ. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: A gene expression analysis on total and microdissected prostate tissue. Am J Pathol 2002;160(6):2169-2180.
12. Kjeldsen L, Cowland JB, Johnsen AH, Borregaard N. SGP28, a novel matrix glycoprotein in specific granules of human neutrophils with similarity to a human testis-specific gene product and a rodent sperm-coating glycoprotein. FEBS Lett 1996;380(3):246-250.
13. Kratzschmar J, Haendler B, Eberspaecher U, Roosterman D, Donner P, Schleuning WD. The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3. Eur J Biochem 1996;236(3):827-836.
14. Udby L, Cowland JB, Johnsen AH, Sorensen OE, Borregaard N, Kjeldsen L. An ELISA for SGP28/CRISP-3, a cysteine-rich secretory protein in human neutrophils, plasma, and exocrine secretions. J Immunol Methods 2002;263(1-2):43-55.
15. Udby L, Bjartell A, Malm J, Egesten A, Lundwall A, Cowland JB, Borregaard N, Kjeldsen L. Characterization and localizaton of cysteine-rich secretory protein 3 (CRISP-3) in human male reproductive tract. J Androl 2005;26(3):333-342.
16. Eberspaecher U, Roosterman D, Kratzschmar J, Haendler B, Habenicht UF, Becker A, Quensel C, Petri T, Schleuning WD, Donner P. Mouse androgen-dependent epididymal glycoprotein CRISP-1 (DE/AEG): Isolation, biochemical characterization, and expression in recombinant form. Mol Reprod Dev 1995;42(2):157-172.
17. Foster JA, Gerton GL. Autoantigen 1 of the guinea pig sperm acrosome is the homologue of mouse Tpx-1 and human TPX1 and is a member of the cysteine-rich secretory protein (CRISP) family. Mol Reprod Dev 1996;44(2):221-229.
18. Schambony A, Gentzel M, Wolfes H, Raida M, Neumann U, Topfer-Petersen E. Equine CRISP-3: Primary structure and expression in the male genital tract. Biochim Biophys Acta 1998;1387(1-2):206-216.
19. Haendler B, Kratzschmar J, Theuring F, Schleuning WD. Transcripts for cysteine-rich secretory protein-1 (CRISP-1; DE/ AEG) and the novel related CRISP-3 are expressed under androgen control in the mouse salivary gland. Endocrinology 1993;133(1):192-198.
20. Yamazaki Y, Koike H, Sugiyama Y, Motoyoshi K, Wada T, Hishinuma S, Mita M, Morita T. Cloning and characterization of novel snake venom proteins that block smooth muscle contraction. Eur J Biochem 2002;269(11):2708-2715.
21. Maeda T, Nishida J, Nakanishi Y. Expression pattern, subcellular localization and structure-function relationship of rat Tpx-1, a spermatogenic cell adhesion molecule responsible for association with Sertoli cells. Dev Growth Differ 1999;41(6):715-722.
22. Mizuki N, Sarapata DE, Garcia-Sanz JA, Kasahara M. The mouse male germ cell-specific gene Tpx-1: Molecular structure, mode of expression in spermatogenesis, and sequence similarity to two non-mammalian genes. Mamm Genome 1992;3(5):274-280.
23. Roberts KP, Wamstad JA, Ensrud KM, Hamilton DW. Inhibition of capacitation-associated tyrosine phosphorylation signaling in rat sperm by epididymal protein Crisp-1. Biol Reprod 2003;69(2):572-581.
24. Cohen DJ, Ellerman DA, Cuasnicu PS. Mammalian sperm-egg fusion: Evidence that epididymal protein DE plays a role in mouse gamete fusion. Biol Reprod 2000;63(2):462-468.
25. Hayashi M, Fujimoto S, Takano H, Ushiki T, Abe K, Ishikura H, Yoshida MC, Kirchhoff C, Ishibashi T, Kasahara M. Characterization of a human glycoprotein with a potential role in sperm-egg fusion: cDNA cloning, immunohistochemical localization, and chromosomal assignment of the gene (AEGL1). Genomics 1996;32(3):367-374.
26. Kim KS, Foster JA, Gerton GL. Differential release of guinea pig sperm acrosomal components during exocytosis. Biol Reprod 2001;64(1):148-156.
27. Stintzi A, Heitz T, Prasad V, Wiedemann-Merdinoglu S, Kauffmann S, Geoffroy P, Legrand M, Fritig B. Plant 'pathogenesis-related' proteins and their role in defense against pathogens. Biochimie 1993;75(8):687-706.
28. Udby L, Calafat J, Sorensen OE, Borregaard N, Kjeldsen L. Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils. J Leukoc Biol 2002;72(3):462-469.
29. Friess H, Ding J, Kleeff J, Liao Q, Berberat PO, Hammer J, Buchler MW. Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 2001;234(6):769-778; discussion 778-769.
30. Tapinos NI, Polihronis M, Thyphronitis G, Moutsopoulos HM. Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjogren's syndrome. Arthritis Rheum 2002;46(1):215-222.
31. Sobin LH, Wittekind C. UICC TNM Classification of malignant tumours. 6th edition. New York: Wiley-Liss; 2002.
32. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32(2):219-229.
33. Bjartell A, Bjork T, Matikainen MT, Abrahamsson PA, di Sant'Agnese A, Lilja H. Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium. Urology 1993;42(5):502-510.
34. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76(9):4350-4354.
35. Farinola MA, Epstein JI. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol 2004;35(10):1272-1278.
36. Haendler B, Schuttke I, Schleuning WD. Androgen receptor signalling: comparative analysis of androgen response elements and implication of heat-shock protein 90 and 14-3-3eta. Mol Cell Endocrinol 2001;173(1-2):63-73.
37. Udby L, Sorensen OE, Pass J, Johnsen AH, Behrendt N, Borregaard N, Kjeldsen L. Cysteine-rich secretory protein 3 is a ligand of alpha1B-glycoprotein in human plasma. Biochemistry 2004;43(40):12877-12886.
38. Udby L, Lundwall Å, Johnsen AH, Fernlund P, Valtonen-André C, Blom A, Borregaard N, Lilja H, Kjeldsen L, Bjartell A. β- microseminoprotein binds CRISP-3 in human seminal plasma. Accepted for publication in Biochem Biophys Res Comm 2005;333(2):555-561.
39. Lilja H, Abrahamsson PA. Three predominant proteins secreted by the human prostate gland. Prostate 1988;12: 29-38.
40. Shukeir N, Arakelian A, Kadhim S, Garde S, Rabbani SA. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer. Cancer Res 2003;63:2072-2078.
41. Garde SV, Basrur VS, Li L, Finkelman MA, Krishan A, Wellham L, Ben-Josef E, Haddad M, Taylor JD, Porter AT, Tang DG. Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis. Prostate 1999;38(2):118-125.
42. Ito Y, Tsuda R, Kimura H. Ultrastructural localizations of beta-microseminoprotein, a prostate-specific antigen, in human prostate and sperm: Comparison with gamma-seminoprotein, another prostate-specific antigen. J Lab Clin Med 1989;114(3): 272-277.
43. Chan PS, Chan LW, Xuan JW, Chin JL, Choi HL, Chan FL. In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates. Prostate 1999;41(2):99-109.
44. Sakai H, Tsurusaki T, Kanda S, Koji T, Xuan JW, Saito Y. Prognostic significance of beta-microseminoprotein mRNA expression in prostate cancer. Prostate 1998;35:109-116.
45. Vanaja DK, Cheville JC, Iturria SJ, Young CY. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res 2003;63(14):3877-3882.
46. Hyakutake H, Sakai H, Yogi Y, Tsuda R, Minami Y, Yushita Y, Kanetake H, Nakazono I, Saito Y. Beta-microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma. Prostate 1993;22(4):347-355.
47. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB. The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004;172:S6-S12.